INSPIRE Pipeline™ Shield Post Approval Study
Public ClinicalTrials.gov record NCT05071963. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Neurovascular Product Surveillance Registry (INSPIRE) Pipeline™ Flex Embolization Device With Shield Technology™ Post Approval Study (PAS)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the Pipeline™ Flex Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Shield PAS") is to collect on-label use data in patients undergoing treatment for intracranial aneurysms (IA) using the Pipeline™ Flex Embolization Device with Shield Technology™ ("Pipeline™ Shield Device") in a real-world post approval setting within the United States.
Study identification
- NCT ID
- NCT05071963
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 246 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 19, 2021
- Primary completion
- Dec 31, 2026
- Completion
- Mar 31, 2028
- Last update posted
- Aug 9, 2026
2021 – 2028
United States locations
- U.S. sites
- 16
- U.S. states
- 14
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Yale New Haven Hospital | New Haven | Connecticut | 06510 | — |
| Baptist Medical Center Jacksonville | Jacksonville | Florida | 32207 | — |
| Emory University Hospital | Atlanta | Georgia | 30322 | — |
| Endeavor Health - Evanston Hospital | Evanston | Illinois | 60201 | — |
| Norton Healthcare | Louisville | Kentucky | 40202 | — |
| Washington University in Saint Louis | St Louis | Missouri | 63130 | — |
| NYU Langone Medical Center | New York | New York | 10016-6402 | — |
| Montefiore Medical Center | New York | New York | 10467-2401 | — |
| The Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Oklahoma (OU) University Medical Center | Oklahoma City | Oklahoma | 73104 | — |
| Geisinger Medical Center | Danville | Pennsylvania | 17822-9800 | — |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Prisma Health | Greenville | South Carolina | 29605 | — |
| Baylor Scott & White Research Institute | Dallas | Texas | 75201 | — |
| University of Utah Hospital | Salt Lake City | Utah | 84132-0001 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05071963, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 9, 2026 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05071963 live on ClinicalTrials.gov.